{"id":56808,"date":"2026-02-10T23:44:07","date_gmt":"2026-02-10T15:44:07","guid":{"rendered":"https:\/\/flcube.com\/?p=56808"},"modified":"2026-02-10T23:44:08","modified_gmt":"2026-02-10T15:44:08","slug":"zhendong-pharmaceutical-secures-china-promotion-rights-to-ferrings-sodium-picosulfate","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=56808","title":{"rendered":"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate"},"content":{"rendered":"\n<p><strong>Shanxi Zhendong Pharmaceutical Co., Ltd.<\/strong> (<strong><a href=\"https:\/\/www.google.com\/finance\/quote\/300158:SHE\">SHE: 300158<\/a><\/strong>) has entered a <strong>strategic partnership<\/strong> with <strong>Ferring Pharmaceuticals Ltd.<\/strong>, the <strong>Switzerland-based specialty pharma company<\/strong>, securing <strong>exclusive promotion rights<\/strong> to <strong>sodium picosulfate<\/strong> in <strong>Mainland China<\/strong>. The bowel cleansing agent partnership expands Zhendong&#8217;s <strong>gastroenterology portfolio<\/strong> while leveraging Ferring&#8217;s <strong>established product brand<\/strong> in the growing <strong>colorectal screening preparation market<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Licensee<\/strong><\/td><td>Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158)<\/td><\/tr><tr><td><strong>Licensor<\/strong><\/td><td>Ferring Pharmaceuticals Ltd. (Switzerland)<\/td><\/tr><tr><td><strong>Asset<\/strong><\/td><td>Sodium picosulfate \u2013 Bowel cleansing agent<\/td><\/tr><tr><td><strong>Territory<\/strong><\/td><td>Mainland China (exclusive promotion rights)<\/td><\/tr><tr><td><strong>Therapeutic Category<\/strong><\/td><td>Gastroenterology\/colonoscopy preparation<\/td><\/tr><tr><td><strong>Deal Type<\/strong><\/td><td>Promotion and distribution partnership<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-profile-amp-market-positioning\">Product Profile &amp; Market Positioning<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Feature<\/th><th>Sodium Picosulfate Specification<\/th><th>Strategic Value<\/th><\/tr><\/thead><tbody><tr><td><strong>Mechanism<\/strong><\/td><td>Stimulant laxative with local action in colon<\/td><td>Effective, predictable bowel cleansing for endoscopic procedures<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Bowel preparation prior to colonoscopy, surgery, or radiological examination<\/td><td>Core enabler of <strong>China&#8217;s expanding colorectal cancer screening programs<\/strong><\/td><\/tr><tr><td><strong>Formulation<\/strong><\/td><td>Oral solution\/tablets<\/td><td>Patient-friendly vs. large-volume PEG solutions<\/td><\/tr><tr><td><strong>Ferring Heritage<\/strong><\/td><td>Established global brand (Picolax, Dulcolax Pico)<\/td><td>Immediate physician recognition and prescribing confidence<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-strategic-rationale\">Market Context &amp; Strategic Rationale<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Factor<\/th><th>Market Implication<\/th><\/tr><\/thead><tbody><tr><td><strong>China Colorectal Screening Expansion<\/strong><\/td><td>National cancer screening programs targeting <strong>&gt;100 million high-risk individuals<\/strong> by 2030; bowel preparation agents essential infrastructure<\/td><\/tr><tr><td><strong>Zhendong Gastroenterology Focus<\/strong><\/td><td>Listed company building <strong>digestive disease franchise<\/strong>; sodium picosulfate complements existing PPI and GI motility portfolio<\/td><\/tr><tr><td><strong>Ferring China Strategy<\/strong><\/td><td>Partnership model leverages <strong>local promotion expertise<\/strong> while retaining manufacturing and regulatory control; capital-efficient market access<\/td><\/tr><tr><td><strong>Competitive Landscape<\/strong><\/td><td>PEG-electrolyte solutions (dominant but poorly tolerated) and sodium phosphate (safety concerns) create opening for <strong>improved tolerability profile<\/strong> of picosulfate<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-commercial-outlook\">Commercial Outlook<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Priority<\/th><th>Execution Plan<\/th><\/tr><\/thead><tbody><tr><td><strong>Hospital Formulary Access<\/strong><\/td><td>Target tier-1\/2 city endoscopy centers and colorectal surgery departments<\/td><\/tr><tr><td><strong>Screening Program Integration<\/strong><\/td><td>Position as preferred bowel prep for government-funded CRC screening initiatives<\/td><\/tr><tr><td><strong>Physician Education<\/strong><\/td><td>Differentiate vs. PEG volumes via tolerability and compliance messaging<\/td><\/tr><tr><td><strong>Retail Pharmacy Expansion<\/strong><\/td><td>Over-the-counter and prescription channel development for outpatient procedures<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding sodium picosulfate commercial performance in China, Zhendong Pharmaceutical&#8217;s gastroenterology market share growth, and Ferring Pharmaceuticals&#8217; partnership expansion strategy. Actual results may differ due to competitive pricing from generic PEG solutions, hospital procurement policy changes, and colorectal screening program funding variability.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158) has entered a strategic partnership with Ferring Pharmaceuticals&#8230;<\/p>\n","protected":false},"author":1,"featured_media":56810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[815,4605,4604],"class_list":["post-56808","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ferring-pharmaceuticals","tag-she-300158","tag-zhendong-pharmaceutical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158) has entered a strategic partnership with Ferring Pharmaceuticals Ltd., the Switzerland-based specialty pharma company, securing exclusive promotion rights to sodium picosulfate in Mainland China. The bowel cleansing agent partnership expands Zhendong&#039;s gastroenterology portfolio while leveraging Ferring&#039;s established product brand in the growing colorectal screening preparation market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=56808\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate\" \/>\n<meta property=\"og:description\" content=\"Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158) has entered a strategic partnership with Ferring Pharmaceuticals Ltd., the Switzerland-based specialty pharma company, securing exclusive promotion rights to sodium picosulfate in Mainland China. The bowel cleansing agent partnership expands Zhendong&#039;s gastroenterology portfolio while leveraging Ferring&#039;s established product brand in the growing colorectal screening preparation market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=56808\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-10T15:44:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-10T15:44:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/1003.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate\",\"datePublished\":\"2026-02-10T15:44:07+00:00\",\"dateModified\":\"2026-02-10T15:44:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808\"},\"wordCount\":364,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/1003.webp\",\"keywords\":[\"Ferring Pharmaceuticals\",\"SHE: 300158\",\"Zhendong Pharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=56808#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=56808\",\"name\":\"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/1003.webp\",\"datePublished\":\"2026-02-10T15:44:07+00:00\",\"dateModified\":\"2026-02-10T15:44:08+00:00\",\"description\":\"Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158) has entered a strategic partnership with Ferring Pharmaceuticals Ltd., the Switzerland-based specialty pharma company, securing exclusive promotion rights to sodium picosulfate in Mainland China. The bowel cleansing agent partnership expands Zhendong's gastroenterology portfolio while leveraging Ferring's established product brand in the growing colorectal screening preparation market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=56808\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/1003.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/1003.webp\",\"width\":1080,\"height\":608,\"caption\":\"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=56808#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate - Insight, China&#039;s Pharmaceutical Industry","description":"Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158) has entered a strategic partnership with Ferring Pharmaceuticals Ltd., the Switzerland-based specialty pharma company, securing exclusive promotion rights to sodium picosulfate in Mainland China. The bowel cleansing agent partnership expands Zhendong's gastroenterology portfolio while leveraging Ferring's established product brand in the growing colorectal screening preparation market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=56808","og_locale":"en_US","og_type":"article","og_title":"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate","og_description":"Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158) has entered a strategic partnership with Ferring Pharmaceuticals Ltd., the Switzerland-based specialty pharma company, securing exclusive promotion rights to sodium picosulfate in Mainland China. The bowel cleansing agent partnership expands Zhendong's gastroenterology portfolio while leveraging Ferring's established product brand in the growing colorectal screening preparation market.","og_url":"https:\/\/flcube.com\/?p=56808","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-10T15:44:07+00:00","article_modified_time":"2026-02-10T15:44:08+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/1003.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=56808#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=56808"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate","datePublished":"2026-02-10T15:44:07+00:00","dateModified":"2026-02-10T15:44:08+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=56808"},"wordCount":364,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=56808#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/1003.webp","keywords":["Ferring Pharmaceuticals","SHE: 300158","Zhendong Pharmaceutical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=56808#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=56808","url":"https:\/\/flcube.com\/?p=56808","name":"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=56808#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=56808#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/1003.webp","datePublished":"2026-02-10T15:44:07+00:00","dateModified":"2026-02-10T15:44:08+00:00","description":"Shanxi Zhendong Pharmaceutical Co., Ltd. (SHE: 300158) has entered a strategic partnership with Ferring Pharmaceuticals Ltd., the Switzerland-based specialty pharma company, securing exclusive promotion rights to sodium picosulfate in Mainland China. The bowel cleansing agent partnership expands Zhendong's gastroenterology portfolio while leveraging Ferring's established product brand in the growing colorectal screening preparation market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=56808#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=56808"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=56808#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/1003.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/1003.webp","width":1080,"height":608,"caption":"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=56808#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Zhendong Pharmaceutical Secures China Promotion Rights to Ferring\u2019s Sodium Picosulfate"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/1003.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/56808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=56808"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/56808\/revisions"}],"predecessor-version":[{"id":56811,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/56808\/revisions\/56811"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/56810"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=56808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=56808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=56808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}